CN103432330A - Traditional Chinese medicine used for treating renal failure and preparation method thereof - Google Patents
Traditional Chinese medicine used for treating renal failure and preparation method thereof Download PDFInfo
- Publication number
- CN103432330A CN103432330A CN2013103179466A CN201310317946A CN103432330A CN 103432330 A CN103432330 A CN 103432330A CN 2013103179466 A CN2013103179466 A CN 2013103179466A CN 201310317946 A CN201310317946 A CN 201310317946A CN 103432330 A CN103432330 A CN 103432330A
- Authority
- CN
- China
- Prior art keywords
- radix
- portions
- chinese medicine
- renal failure
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract 14
- 208000001647 Renal Insufficiency Diseases 0.000 title claims abstract 9
- 201000006370 kidney failure Diseases 0.000 title claims abstract 9
- 238000002360 preparation method Methods 0.000 title claims abstract 3
- 239000002994 raw material Substances 0.000 claims abstract 6
- 244000291333 Serissa japonica Species 0.000 claims abstract 5
- 239000007788 liquid Substances 0.000 claims 5
- 241000628997 Flos Species 0.000 claims 4
- 239000009636 Huang Qi Substances 0.000 claims 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims 4
- 238000009835 boiling Methods 0.000 claims 2
- 230000014759 maintenance of location Effects 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 241000405414 Rehmannia Species 0.000 abstract 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 241001080798 Polygala tenuifolia Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 240000001638 Scurrula parasitica Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 244000237330 gutta percha tree Species 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine used for treating renal failure and a preparation method thereof. The traditional Chinese medicine comprises following raw materials, by weight, 30 to 60 portions of raw astragali radix, 10 to 30 portions of raw rehmannia root, 10 to 30 portions of prepared rehmannia root, 10 to 30 portions of Chinese yam, 5 to 20 portions of angelica sinensis, 10 to 30 portions of radix pseudostellariae, 10 to 30 portions of eucommia ulmoides, 10 to 30 portions of loranthus parasiticus, 10 to 30 portions of polygala tenuifolia, 10 to 30 portions of poria cocos, 10 to 30 portions of rheum officinale, 5 to 20 portions of safflower carthamus, 4 to 8 portions of licorice, 10 to 30 portions of radix cyathulae, 10 to 30 portions of herba epimedii, 10 to 30 portions of radix dipsaci, 10 to 30 portions of rhizoma atractylodis macrocephalae, 10 to 30 portions of fried fructus aurantii and 30 to 60 portions of serissa serissoides. The results of more than 110 clinical experiments show that: effective rate of the traditional Chinese medicine in treatment of renal failure reaches to 82%, and 50% of the patients treated by using the traditional Chinese medicine are on the mend obviously. No toxic or side effect is caused by the traditional Chinese medicine, and the traditional Chinese medicine is capable of improving renal failure significantly. In addition, the traditional Chinese medicine is low in cost, is easy to prepare, can be popularized in the folk, and is capable of reducing medicine burden of patients.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly a kind of Chinese medicine for the treatment of renal failure and preparation method thereof.
Background technology
Chronic glomerulonephritis can betide any age, but take green grass or young crops, middle age as main.Most insidious onsets, slowly, take hematuria, albuminuria, hypertension, edema is its basic clinical.Generally speaking, all have urine examination abnormal (hematuria, albuminuria, cylinderuria), edema and a hypertension history, course of disease delay, and guiding treatment and judging prognosis can be made a definite diagnosis and be conducive to the pathology of the renal biopsies inspection.Renal failure should give corresponding determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs for its histological type in early days.
Existing doctor trained in Western medicine is mainly the Immunosuppression transmitting inflammation, suppresses cell proliferation, alleviates Nephrosclerosis for the treatment of renal failure.And should take and prevent or delay renal function carrying out property deterioration, improvement or alleviate clinical symptoms and prevent and treat complication as main purpose.But the existing western medical treatment generally cure rate for renal failure is very low.Effect is undesirable.
Summary of the invention
Low for the cure rate of renal failure in order to solve the prior art Chinese and western medicine, the problem that effect is undesirable, the embodiment of the present invention has proposed a kind of Chinese medicine for the treatment of renal failure and preparation method thereof.Described technical scheme is as follows:
Embodiments of the invention have proposed a kind of Chinese medicine for the treatment of renal failure, the raw material of following weight ratio, consist of: Radix Astragali 30-60; Radix Rehmanniae 10-30; Radix Rehmanniae Preparata 10-30; Rhizoma Dioscoreae 10-30; Radix Angelicae Sinensis 5-20; Radix Pseudostellariae 10-30; Cortex Eucommiae 10-30; Herba Taxilli 10-30; Radix Polygalae 10-30; Poria 10-30; Radix Et Rhizoma Rhei 10-30; Flos Carthami 5-20; Radix Glycyrrhizae 4-8; Radix Cyathulae 10-30; Herba Epimedii 10-30; Radix Dipsaci 10-30; Rhizoma Atractylodis Macrocephalae 10-30; Fructus Aurantii (parched) 10-30; Serissa foetida 30-60.
As technique scheme preferably, the Chinese medicine of described treatment renal failure is comprised of the raw material of following weight ratio: Radix Astragali 30; Radix Rehmanniae 15; Radix Rehmanniae Preparata 15; Rhizoma Dioscoreae 15; Radix Angelicae Sinensis 10; Radix Pseudostellariae 15; The Cortex Eucommiae 15; Herba Taxilli 15; Radix Polygalae 15; Poria 15; Radix Et Rhizoma Rhei 15; Flos Carthami 10; Radix Glycyrrhizae 6; Radix Cyathulae 15; Herba Epimedii 15; Radix Dipsaci 15; The Rhizoma Atractylodis Macrocephalae 15; Fructus Aurantii (parched) 15; Serissa foetida 30.
As technique scheme preferably, the Chinese medicine of described treatment renal failure is comprised of the raw material of following weight ratio: Radix Astragali 30; Radix Rehmanniae 10; Radix Rehmanniae Preparata 10; Rhizoma Dioscoreae 10; Radix Angelicae Sinensis 5; Radix Pseudostellariae 10; The Cortex Eucommiae 10; Herba Taxilli 10; Radix Polygalae 10; Poria 10; Radix Et Rhizoma Rhei 10; Flos Carthami 5; Radix Glycyrrhizae 4; Radix Cyathulae 10; Herba Epimedii 10; Radix Dipsaci 10; The Rhizoma Atractylodis Macrocephalae 10; Fructus Aurantii (parched) 10; Serissa foetida 30.
As technique scheme preferably, the Chinese medicine of described treatment renal failure is comprised of the raw material of following weight ratio: Radix Astragali 60; Radix Rehmanniae 30; Radix Rehmanniae Preparata 30; Rhizoma Dioscoreae 30; Radix Angelicae Sinensis 20; Radix Pseudostellariae 30; The Cortex Eucommiae 30; Herba Taxilli 30; Radix Polygalae 30; Poria 30; Radix Et Rhizoma Rhei 30; Flos Carthami 20; Radix Glycyrrhizae 8; Radix Cyathulae 30; Herba Epimedii 30; Radix Dipsaci 30; The Rhizoma Atractylodis Macrocephalae 30; Fructus Aurantii (parched) 30; Serissa foetida 60.
Simultaneously, the embodiment of the present invention has also proposed a kind of preparation method of Chinese medicine for the treatment of renal failure as described as front any one, comprising:
After above-mentioned raw materials is fully mixed except Radix Et Rhizoma Rhei, at room temperature soak 30-60 minute; ,
After adding water and making liquid level surpass powder; After boiling with big fire, change slow fire boiling 25-40 minute; Add Radix Et Rhizoma Rhei, continue to decoct 10 minutes; Then medicinal liquid is poured out to retention;
Then again add water and make liquid level and powder maintains an equal level, continuing to boil decocts 15-25 minute; Medicinal liquid after decocting is mixed with the retention medicinal liquid.
The invention has the beneficial effects as follows: through the clinical trial that surpasses 110 examples, show, this Chinese medicine reaches 82% at effective percentage aspect treatment renal failure, and wherein 50% case takes an evident turn for the better.This Chinese medicine no side effects simultaneously, can be to the renal failure effect that improves significantly.This medicine cost is low simultaneously, and easily preparation can, in popularization among the people, reduce the medication burden of sufferer.
The specific embodiment
Below technical scheme of the present invention is clearly and completely described, obviously, described embodiment is only the present invention's part embodiment, rather than whole embodiment.Embodiment based in the present invention, those of ordinary skills, not making under the creative work prerequisite the every other embodiment obtained, belong to the scope of protection of the invention.
Embodiments of the invention have proposed a kind of Chinese medicine for the treatment of renal failure, the raw material of following weight ratio, consist of: Radix Astragali 30-60; Radix Rehmanniae 10-30; Radix Rehmanniae Preparata 10-30; Rhizoma Dioscoreae 10-30; Radix Angelicae Sinensis 5-20; Radix Pseudostellariae 10-30; Cortex Eucommiae 10-30; Herba Taxilli 10-30; Radix Polygalae 10-30; Poria 10-30; Radix Et Rhizoma Rhei 10-30; Flos Carthami 5-20; Radix Glycyrrhizae 4-8; Radix Cyathulae 10-30; Herba Epimedii 10-30; Radix Dipsaci 10-30; Rhizoma Atractylodis Macrocephalae 10-30; Fructus Aurantii (parched) 10-30; Serissa foetida 30-60.
Preferably, the Chinese medicine of described treatment renal failure is comprised of the raw material of following weight ratio: Radix Astragali 30; Radix Rehmanniae 15; Radix Rehmanniae Preparata 15; Rhizoma Dioscoreae 15; Radix Angelicae Sinensis 10; Radix Pseudostellariae 15; The Cortex Eucommiae 15; Herba Taxilli 15; Radix Polygalae 15; Poria 15; Radix Et Rhizoma Rhei 15; Flos Carthami 10; Radix Glycyrrhizae 6; Radix Cyathulae 15; Herba Epimedii 15; Radix Dipsaci 15; The Rhizoma Atractylodis Macrocephalae 15; Fructus Aurantii (parched) 15; Serissa foetida 30.
Preferably, the Chinese medicine of described treatment renal failure is comprised of the raw material of following weight ratio: Radix Astragali 30; Radix Rehmanniae 10; Radix Rehmanniae Preparata 10; Rhizoma Dioscoreae 10; Radix Angelicae Sinensis 5; Radix Pseudostellariae 10; The Cortex Eucommiae 10; Herba Taxilli 10; Radix Polygalae 10; Poria 10; Radix Et Rhizoma Rhei 10; Flos Carthami 5; Radix Glycyrrhizae 4; Radix Cyathulae 10; Herba Epimedii 10; Radix Dipsaci 10; The Rhizoma Atractylodis Macrocephalae 10; Fructus Aurantii (parched) 10; Serissa foetida 30.
Preferably, the Chinese medicine of described treatment renal failure is comprised of the raw material of following weight ratio: Radix Astragali 60; Radix Rehmanniae 30; Radix Rehmanniae Preparata 30; Rhizoma Dioscoreae 30; Radix Angelicae Sinensis 20; Radix Pseudostellariae 30; The Cortex Eucommiae 30; Herba Taxilli 30; Radix Polygalae 30; Poria 30; Radix Et Rhizoma Rhei 30; Flos Carthami 20; Radix Glycyrrhizae 8; Radix Cyathulae 30; Herba Epimedii 30; Radix Dipsaci 30; The Rhizoma Atractylodis Macrocephalae 30; Fructus Aurantii (parched) 30; Serissa foetida 60.
Simultaneously, the embodiment of the present invention has also proposed a kind of preparation method of Chinese medicine for the treatment of renal failure as described as front any one, comprising:
After above-mentioned raw materials is fully mixed except Radix Et Rhizoma Rhei, at room temperature soak 30-60 minute; ,
After adding water and making liquid level surpass powder; After boiling with big fire, change slow fire boiling 25-40 minute; Add Radix Et Rhizoma Rhei, continue to decoct 10 minutes; Then medicinal liquid is poured out to retention;
Then again add water and make liquid level and powder maintains an equal level, continuing to boil decocts 15-25 minute; Medicinal liquid after decocting is mixed with the retention medicinal liquid.
Wherein:
Radix Astragali: have another name called the Radix Astragali, can mend the gas of the whole body, have yang invigorating concurrently, strengthening superficial resistance to stop perspiration, evacuation of pus granulation promoting, inducing diuresis to remove edema, the effect of antiabortive beneficial blood.
Radix Rehmanniae: the clearing away heat and promoting production of body fluid YIN nourishing, nourish blood.
Radix Rehmanniae Preparata: enrich blood moist; The benefit essence is filled out marrow.
Rhizoma Dioscoreae: have another name called Rhizoma Dioscoreae; The spleen reinforcing nourishing the stomach, the lung benefiting that promotes the production of body fluid, the kidney invigorating arresting seminal emission.
Radix Angelicae Sinensis: enrich blood; Invigorate blood circulation; Menstruction regulating and pain relieving; Moisturize laxation.
Radix Pseudostellariae: replenishing QI to invigorate the spleen, promoting the production of body fluid for nourishing the lung.
The Cortex Eucommiae: invigorating the liver and kidney, bone and muscle strengthening, adjusting blood pressure.
Herba Taxilli: invigorating the liver and kidney; Bone and muscle strengthening; Wind-damp dispelling; Antiabortive.
Radix Polygalae: the Fructus Alpiniae Oxyphyllae of calming the nerves, eliminate the phlegm, subside a swelling.
Poria: promoting diuresis to eliminate damp pathogen, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.
Radix Et Rhizoma Rhei: attack stagnant; Clearing away damp-heat; Pathogenic fire purging; Removing heat from blood; Blood stasis dispelling; Removing toxic substances.
Flos Carthami: promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving.
Radix Glycyrrhizae: heat-clearing and toxic substances removing, expelling phlegm for arresting cough, gastral cavity abdomen.
Radix Cyathulae: have another name called Radix Achyranthis Bidentatae, promoting blood circulation to restore menstrual flow, expelling wind and removing dampness, easing joint movement, inducing diuresis for treating stranguria syndrome.
Herba Epimedii: kidney-replenishing, bone and muscle strengthening, wind-damp dispelling.
Radix Dipsaci: invigorating the liver and kidney; Bone and muscle strengthening; Blood circulation regulating; Continuous folding wound; Only metrorrhagia.
The Rhizoma Atractylodis Macrocephalae: invigorating the spleen and benefiting QI, the dampness diuretic, hidroschesis, antiabortive.
Fructus Aurantii (parched): regulating the flow of QI to ease the stomach, the stagnant relieving distension of row.
Serissa foetida: invigorating spleen to remove dampness, soothing liver-QI is invigorated blood circulation.
Below by several model cases, the drug effect to the Chinese medicine of the embodiment of the present invention describes:
Case 1
61 years old address of Chen man: Changning district, Shanghai Chang Ninglu
Symptom: renal failure (renal insufficiency).
Prescription: Radix Astragali 60; Radix Rehmanniae 30; Radix Rehmanniae Preparata 30; Rhizoma Dioscoreae 30; Radix Angelicae Sinensis 20; Radix Pseudostellariae 30; The Cortex Eucommiae 30; Herba Taxilli 30; Radix Polygalae 30; Poria 30; Radix Et Rhizoma Rhei 30; Flos Carthami 20; Radix Glycyrrhizae 8; Radix Cyathulae 30; Herba Epimedii 30; Radix Dipsaci 30; The Rhizoma Atractylodis Macrocephalae 30; Fructus Aurantii (parched) 30; Serissa foetida 60.
After taking one month, the state of an illness alleviates to some extent.After taking three months, the state of an illness is clearly better, and after 1 year, recovers.
Case 2
Lee so-and-so man 61 years old address: Henan Hebi City Heshan District
Symptom: renal failure initial stage
Prescription: Radix Astragali 30; Radix Rehmanniae 15; Radix Rehmanniae Preparata 15; Rhizoma Dioscoreae 15; Radix Angelicae Sinensis 10; Radix Pseudostellariae 15; The Cortex Eucommiae 15; Herba Taxilli 15; Radix Polygalae 15; Poria 15; Radix Et Rhizoma Rhei 15; Flos Carthami 10; Radix Glycyrrhizae 6; Radix Cyathulae 15; Herba Epimedii 15; Radix Dipsaci 15; The Rhizoma Atractylodis Macrocephalae 15; Fructus Aurantii (parched) 15; Serissa foetida 30.
After taking one month, the state of an illness alleviates to some extent.After taking three months, the state of an illness is clearly better, and after half a year, recovers.
Case 3
The week so-and-so
Symptom: renal failure initial stage
Prescription: the Chinese medicine of described treatment renal failure is comprised of the raw material of following weight ratio: Radix Astragali 30; Radix Rehmanniae 10; Radix Rehmanniae Preparata 10; Rhizoma Dioscoreae 10; Radix Angelicae Sinensis 5; Radix Pseudostellariae 10; The Cortex Eucommiae 10; Herba Taxilli 10; Radix Polygalae 10; Poria 10; Radix Et Rhizoma Rhei 10; Flos Carthami 5; Radix Glycyrrhizae 4; Radix Cyathulae 10; Herba Epimedii 10; Radix Dipsaci 10; The Rhizoma Atractylodis Macrocephalae 10; Fructus Aurantii (parched) 10; Serissa foetida 30.
After taking one month, the state of an illness alleviates to some extent.After taking three months, the state of an illness is clearly better.
The above; be only the specific embodiment of the present invention, protection scope of the present invention is not limited to this, anyly is familiar with those skilled in the art in the technical scope that the present invention discloses; can expect easily changing or replacing, within all should being encompassed in protection scope of the present invention.Therefore, protection scope of the present invention should be as the criterion by the described protection domain with claim.
Claims (5)
1. a Chinese medicine for the treatment of renal failure, is characterized in that, the raw material of following weight ratio, consists of: Radix Astragali 30-60; Radix Rehmanniae 10-30; Radix Rehmanniae Preparata 10-30; Rhizoma Dioscoreae 10-30; Radix Angelicae Sinensis 5-20; Radix Pseudostellariae 10-30; Cortex Eucommiae 10-30; Herba Taxilli 10-30; Radix Polygalae 10-30; Poria 10-30; Radix Et Rhizoma Rhei 10-30; Flos Carthami 5-20; Radix Glycyrrhizae 4-8; Radix Cyathulae 10-30; Herba Epimedii 10-30; Radix Dipsaci 10-30; Rhizoma Atractylodis Macrocephalae 10-30; Fructus Aurantii (parched) 10-30; Serissa foetida 30-60.
2. the Chinese medicine for the treatment of renal failure according to claim 1, is characterized in that, the raw material of following weight ratio, consists of: Radix Astragali 30; Radix Rehmanniae 15; Radix Rehmanniae Preparata 15; Rhizoma Dioscoreae 15; Radix Angelicae Sinensis 10; Radix Pseudostellariae 15; The Cortex Eucommiae 15; Herba Taxilli 15; Radix Polygalae 15; Poria 15; Radix Et Rhizoma Rhei 15; Flos Carthami 10; Radix Glycyrrhizae 6; Radix Cyathulae 15; Herba Epimedii 15; Radix Dipsaci 15; The Rhizoma Atractylodis Macrocephalae 15; Fructus Aurantii (parched) 15; Serissa foetida 30.
3. the Chinese medicine for the treatment of renal failure according to claim 1, is characterized in that, the raw material of following weight ratio, consists of: Radix Astragali 30; Radix Rehmanniae 10; Radix Rehmanniae Preparata 10; Rhizoma Dioscoreae 10; Radix Angelicae Sinensis 5; Radix Pseudostellariae 10; The Cortex Eucommiae 10; Herba Taxilli 10; Radix Polygalae 10; Poria 10; Radix Et Rhizoma Rhei 10; Flos Carthami 5; Radix Glycyrrhizae 4; Radix Cyathulae 10; Herba Epimedii 10; Radix Dipsaci 10; The Rhizoma Atractylodis Macrocephalae 10; Fructus Aurantii (parched) 10; Serissa foetida 30.
4. the Chinese medicine for the treatment of renal failure according to claim 1, is characterized in that, the raw material of following weight ratio, consists of: Radix Astragali 60; Radix Rehmanniae 30; Radix Rehmanniae Preparata 30; Rhizoma Dioscoreae 30; Radix Angelicae Sinensis 20; Radix Pseudostellariae 30; The Cortex Eucommiae 30; Herba Taxilli 30; Radix Polygalae 30; Poria 30; Radix Et Rhizoma Rhei 30; Flos Carthami 20; Radix Glycyrrhizae 8; Radix Cyathulae 30; Herba Epimedii 30; Radix Dipsaci 30; The Rhizoma Atractylodis Macrocephalae 30; Fructus Aurantii (parched) 30; Serissa foetida 60.
5. the preparation method as the Chinese medicine of the described treatment renal failure of claim 1-4 any one, is characterized in that, comprising:
After above-mentioned raw materials is fully mixed except Radix Et Rhizoma Rhei, at room temperature soak 30-60 minute; ,
After adding water and making liquid level surpass powder; After boiling with big fire, change slow fire boiling 25-40 minute; Add Radix Et Rhizoma Rhei, continue to decoct 10 minutes; Then medicinal liquid is poured out to retention;
Then again add water and make liquid level and powder maintains an equal level, continuing to boil decocts 15-25 minute; Medicinal liquid after decocting is mixed with the retention medicinal liquid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310317946.6A CN103432330B (en) | 2013-07-26 | 2013-07-26 | Traditional Chinese medicine used for treating renal failure and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310317946.6A CN103432330B (en) | 2013-07-26 | 2013-07-26 | Traditional Chinese medicine used for treating renal failure and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103432330A true CN103432330A (en) | 2013-12-11 |
CN103432330B CN103432330B (en) | 2015-03-18 |
Family
ID=49686115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310317946.6A Expired - Fee Related CN103432330B (en) | 2013-07-26 | 2013-07-26 | Traditional Chinese medicine used for treating renal failure and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103432330B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104147353A (en) * | 2014-07-09 | 2014-11-19 | 南阳市宛城区第一人民医院 | Traditional Chinese medicine enema for treating early and middle-stage chronic renal failure |
CN105031413A (en) * | 2015-09-18 | 2015-11-11 | 全椒先奇医药科技有限公司 | Pharmaceutic preparation for treating chronic renal failure |
CN110934952A (en) * | 2019-12-25 | 2020-03-31 | 陈喜山 | Traditional Chinese medicine composition and preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101381668A (en) * | 2008-09-18 | 2009-03-11 | 何官平 | Method for preparing health-care medicinal liquor |
-
2013
- 2013-07-26 CN CN201310317946.6A patent/CN103432330B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101381668A (en) * | 2008-09-18 | 2009-03-11 | 何官平 | Method for preparing health-care medicinal liquor |
Non-Patent Citations (2)
Title |
---|
王济生: "中医药延缓慢性肾功能衰竭进程的研究进展", 《山东中医杂志》 * |
陈二军等: "慢性肾功能衰竭辨治心得", 《中医杂志》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104147353A (en) * | 2014-07-09 | 2014-11-19 | 南阳市宛城区第一人民医院 | Traditional Chinese medicine enema for treating early and middle-stage chronic renal failure |
CN104147353B (en) * | 2014-07-09 | 2017-11-24 | 南阳市宛城区第一人民医院 | It is a kind of to treat morning, the Chinese medicinal enema of mid-term chronic renal failure |
CN105031413A (en) * | 2015-09-18 | 2015-11-11 | 全椒先奇医药科技有限公司 | Pharmaceutic preparation for treating chronic renal failure |
CN110934952A (en) * | 2019-12-25 | 2020-03-31 | 陈喜山 | Traditional Chinese medicine composition and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN103432330B (en) | 2015-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103211885B (en) | Chinese medicinal composition for treatment of chronic urticaria | |
CN104740202A (en) | Medicine for treating skin itch | |
CN103720996A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
CN103272096A (en) | Traditional Chinese medicine for treating dysmenorrhea | |
CN102462827A (en) | Traditional Chinese medicine powder formula for treating postpartum mastitis of Boer goats | |
CN103432330B (en) | Traditional Chinese medicine used for treating renal failure and preparation method thereof | |
CN103272143A (en) | Traditional Chinese medicine composition for treating acne | |
CN104784538B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of diabetes | |
CN104013806B (en) | A kind of Chinese prescription for being used to treat diabetes | |
CN103623385B (en) | A kind of Chinese medicine for the treatment of oral ulcer | |
CN103432467B (en) | Traditional Chinese medicine used for treating uremia and preparation method thereof | |
CN104001146A (en) | Traditional Chinese medicine composition for curing dysmenorrhea | |
CN102935214B (en) | Traditional Chinese medicinal composition for treating uremia | |
CN104984313A (en) | Traditional Chinese medicine medicinal wine for treating chilblain | |
CN105106895A (en) | Compound traditional Chinese medicine oral solution for treating nephritis and preparation process thereof | |
CN104257908A (en) | Traditional Chinese medicine preparation for treating rheumatic arthritis and preparation method, | |
CN103566245B (en) | A kind of medicine for the treatment of nephropathy | |
CN102335407A (en) | Chinese medicinal composition for treating acute gastric dilatation of horses | |
CN102552521A (en) | Traditional Chinese medicine composition for treating behcet disease | |
CN100998720B (en) | Oral traditional Chinese medicine for treating amenorrhea of uterus stasis | |
CN105169036A (en) | Traditional Chinese medicinal composition for treating sicca syndrome | |
CN103405606B (en) | Traditional Chinese medicine preparation for treating primary dysmenorrhea | |
CN104306943A (en) | Traditional Chinese medicine combination for curing hyperlipidemia | |
CN104771743A (en) | Traditional Chinese medicine preparation for treating enteritis | |
CN105617178A (en) | Traditional Chinese medicine composition for treating epidemic parotitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150318 Termination date: 20180726 |
|
CF01 | Termination of patent right due to non-payment of annual fee |